Adding metformin to chemoradiation for locally advanced non-small cell lung cancer doesn't yield survival benefits
A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were ...
Aug 24, 2021
0
283